logo
12:03 Feb 26

Lyka Labs Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
63.88
+2.06 (+3.33%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Lyka Labs Ltd. Financials

Lyka Labs Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
63.88
+2.06 (+3.33%)
12:03 Feb 26
Quality
image/svg+xml

75/100
High Financial Strength

Valuation
image/svg+xml

18/100
Expensive Valuation

Technical

27/100
Technically Bearish

Strength

11

Weakness

6

Opportunity

0

Threats

0

7.73 %

ROE %

4.54 %

ROA %

-0.18

EPS

29.01

BVPS

5.78 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
86.25 194.08 93.07 111.19 138.5
Operating Expenses +
66.57 92.93 76.23 95.48 120.56
Raw Material
34.91 53.39 38.77 45.63 56.95
Increase Decrease in Cost
3.06 -0.41 -1.21 -0.78 -1.36
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
14.57 18.06 18.61 26.77 34.63
Miscellaneous Expenses
59.23 74.79 51.44 50.84 70.1
Operating Profit
19.68 101.15 16.84 15.71 17.94
Other Income
1.56 2.09 3.4 1.45 2.23
Depreciation
8.32 17.35 14.15 12.8 6.77
Interest
25.94 20.13 11.87 4.89 2.27
Profit before tax and exceptio..
-13.02 65.77 -5.78 -0.52 11.12
Exceptional Items
-1.13 -6.52 -7.39 -0.41 0
PBT
-14.14 59.25 -13.17 -0.93 11.12
Provision for Taxation
-4.05 20.8 -0.02 1.69 3.19
Net Profit
-10.09 38.44 -13.15 -2.62 7.93
NET Profit after MI
-11.55 39 -13.21 -2.49 8.01
EPS
-4.07 13.57 -4.63 -0.79 2.22
Operating Profit Margin (%)
22.82 52.12 18.09 14.13 12.95
Net Profit Margin (%)
-13.39 20.09 -14.19 -2.24 5.78

Lyka Labs Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 58.20 58.20 58.20 58.20 58.10 58.10
FII 0.20 0.20 0.20 0.20 0.20 0.20
Public 0.60 0.60 0.60 0.70 0.60 0.60
Others 41.00 41.00 41.00 40.90 41.10 41.10
Shareholder Shares Holding %
Research 360 logo
Download Our App On: